Skip to main content
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1997 Aug;167(2):103–105.

Development of hepatocellular carcinoma after clearance of hepatitis C virus with interferon therapy.

M J Tong 1, L P Lai 1, K Murakami-Mori 1
PMCID: PMC1304438  PMID: 9291751

Full text

PDF
103

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  2. De Mitri M. S., Poussin K., Baccarini P., Pontisso P., D'Errico A., Simon N., Grigioni W., Alberti A., Beaugrand M., Pisi E. HCV-associated liver cancer without cirrhosis. Lancet. 1995 Feb 18;345(8947):413–415. doi: 10.1016/s0140-6736(95)90400-x. [DOI] [PubMed] [Google Scholar]
  3. Gerber M. A., Shieh Y. S., Shim K. S., Thung S. N., Demetris A. J., Schwartz M., Akyol G., Dash S. Detection of replicative hepatitis C virus sequences in hepatocellular carcinoma. Am J Pathol. 1992 Dec;141(6):1271–1277. [PMC free article] [PubMed] [Google Scholar]
  4. Hirashima N., Mizokami M., Orito E., Koide T., Itazu I., Kumada K., Sakakibara K., Kano H., Lau J. Y. Case report: development of hepatocellular carcinoma in a patient with chronic hepatitis C infection after a complete and sustained response to interferon-alpha. J Gastroenterol Hepatol. 1996 Oct;11(10):955–958. [PubMed] [Google Scholar]
  5. Hwang S. J., Tong M. J., Lai P. P., Ko E. S., Co R. L., Chien D., Kuo G. Evaluation of hepatitis B and C viral markers: clinical significance in Asian and Caucasian patients with hepatocellular carcinoma in the United States of America. J Gastroenterol Hepatol. 1996 Oct;11(10):949–954. [PubMed] [Google Scholar]
  6. Mazzella G., Accogli E., Sottili S., Festi D., Orsini M., Salzetta A., Novelli V., Cipolla A., Fabbri C., Pezzoli A. Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis. J Hepatol. 1996 Feb;24(2):141–147. doi: 10.1016/s0168-8278(96)80022-5. [DOI] [PubMed] [Google Scholar]
  7. Nishiguchi S., Kuroki T., Nakatani S., Morimoto H., Takeda T., Nakajima S., Shiomi S., Seki S., Kobayashi K., Otani S. Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet. 1995 Oct 21;346(8982):1051–1055. doi: 10.1016/s0140-6736(95)91739-x. [DOI] [PubMed] [Google Scholar]
  8. Pontisso P., Ruvoletto M. G., Fattovich G., Chemello L., Gallorini A., Ruol A., Alberti A. Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterology. 1993 Nov;105(5):1529–1533. doi: 10.1016/0016-5085(93)90161-5. [DOI] [PubMed] [Google Scholar]
  9. Romeo R., Pol S., Berthelot P., Brechot C. Eradication of hepatitis C virus RNA after alpha-interferon therapy. Ann Intern Med. 1994 Aug 15;121(4):276–277. doi: 10.7326/0003-4819-121-4-199408150-00008. [DOI] [PubMed] [Google Scholar]
  10. Sharara A. I., Hunt C. M., Hamilton J. D. Hepatitis C. Ann Intern Med. 1996 Oct 15;125(8):658–668. doi: 10.7326/0003-4819-125-8-199610150-00006. [DOI] [PubMed] [Google Scholar]
  11. Shindo M., Arai K., Sokawa Y., Okuno T. Hepatic hepatitis C virus RNA as a predictor of a long-term response to interferon-alpha therapy. Ann Intern Med. 1995 Apr 15;122(8):586–591. doi: 10.7326/0003-4819-122-8-199504150-00005. [DOI] [PubMed] [Google Scholar]
  12. Simonetti R. G., Cammà C., Fiorello F., Cottone M., Rapicetta M., Marino L., Fiorentino G., Craxì A., Ciccaglione A., Giuseppetti R. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study. Ann Intern Med. 1992 Jan 15;116(2):97–102. doi: 10.7326/0003-4819-116-2-97. [DOI] [PubMed] [Google Scholar]
  13. Tong M. J., Lee S. Y., Hwang S. J., Co R. L., Lai P. P., Chien D., Kuo G. Evidence for hepatitis C viral infection in patients with primary hepatocellular carcinoma. West J Med. 1994 Feb;160(2):133–138. [PMC free article] [PubMed] [Google Scholar]
  14. Tsukuma H., Hiyama T., Tanaka S., Nakao M., Yabuuchi T., Kitamura T., Nakanishi K., Fujimoto I., Inoue A., Yamazaki H. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med. 1993 Jun 24;328(25):1797–1801. doi: 10.1056/NEJM199306243282501. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES